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Subsequently to the publication of this article, the authors have realized that [Fig. 4](#f4-mmr-20-05-4391){ref-type="fig"} contained some incorrectly incorporated data panels; specifically, the A-d, B-b and B-c panels did not display the correct data. The revised version of [Fig. 4](#f4-mmr-20-05-4391){ref-type="fig"} featuring the correct data for the A-d, B-b and B-c panels is shown on the next page.

Note that these errors did not affect the overall conclusions reported in the paper. The authors apologize to the Editor of *Molecular Medicine Reports* and to readership for any inconvenience caused.

![Retinal imaging using FA in each group. (A) Results of the fundus examination using FA prior to drug intervention in the (a) normal, (b) DM, (c) Met, (d) TNTL-h, (e) TNTL-m and (f) TNTL-1 groups. (B) Results of the fundus examination using FA after the 18-week drug intervention in the (a) normal, (b) DM, (c) Met, (d) TNTL-h, (e) TNTL-m and (f) TNTL-1 groups. Magnification, ×40. Normal, C57BL mice; DM, untreated C57BLdb/db mice; Met, C57BLdb/db mice treated with metformin; TNTL-h, TNTL-m and TNTL-l, C57BLdb/db mice treated with 1.8, 0.9 and 0.45 g/kg body weight Tangningtongluo, respectively. FA, fluorescein angiography.](MMR-20-05-4391-g00){#f4-mmr-20-05-4391}
